LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 207 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $344,840 | -16.7% | 5,755 | 0.0% | 0.00% | -20.0% |
| Q2 2023 | $414,187 | -1.9% | 5,755 | 0.0% | 0.01% | -16.7% |
| Q1 2023 | $422,359 | +10.1% | 5,755 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $383,743 | -22.6% | 5,755 | 0.0% | 0.01% | -25.0% |
| Q3 2022 | $496,000 | -3.1% | 5,755 | 0.0% | 0.01% | +14.3% |
| Q2 2022 | $512,000 | -71.3% | 5,755 | -63.8% | 0.01% | -66.7% |
| Q1 2022 | $1,786,000 | -29.4% | 15,914 | -1.8% | 0.02% | -25.0% |
| Q4 2021 | $2,531,000 | +2.1% | 16,205 | -9.0% | 0.03% | 0.0% |
| Q3 2021 | $2,479,000 | +6.2% | 17,808 | 0.0% | 0.03% | +16.7% |
| Q2 2021 | $2,334,000 | -14.0% | 17,808 | 0.0% | 0.02% | -11.1% |
| Q1 2021 | $2,713,000 | -7.5% | 17,808 | -39.6% | 0.03% | -10.0% |
| Q4 2020 | $2,934,000 | – | 29,504 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |